Pathios Therapeutics Limited
Pathios Therapeutics Limited is an active company incorporated on 27 February 2017 with the registered office located in Abingdon, Oxfordshire. Pathios Therapeutics Limited was registered 8 years ago.
Status
Active
Active since incorporation
Company No
10641754
Private limited company
Age
8 years
Incorporated 27 February 2017
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 26 February 2025 (10 months ago)
Next confirmation dated 26 February 2026
Due by 12 March 2026 (1 month remaining)
Last change occurred 10 months ago
Accounts
Submitted
For period 1 Jan ⟶ 31 Dec 2024 (1 year)
Accounts type is Small
Next accounts for period 31 December 2025
Due by 30 September 2026 (8 months remaining)
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Brenton Karl Ahrens and Thomas David McCarthy are mutual people.
Active
Thomas David McCarthy is a mutual person.
Active
Brands
Pathios Therapeutics is a clinical-stage oncology and immunology company focused on targeting the acid-sensing GPCR, GPR65, to address the underlying biology of immune cell dysfunction in the acidic tumor microenvironment..
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Period Ended
31 Dec 2024
For period 31 Dec ⟶ 31 Dec 2024
Traded for 12 months
Cash in Bank
£3.25M
Increased by £466K (+17%)
Turnover
Unreported
Same as previous period
Employees
7
Decreased by 1 (-13%)
Total Assets
£5.53M
Increased by £1.06M (+24%)
Total Liabilities
-£677K
Decreased by £20K (-3%)
Net Assets
£4.85M
Increased by £1.08M (+29%)
Debt Ratio (%)
12%
Decreased by 3.35% (-21%)
Get Credit Report
Discover Pathios Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
